{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:40:48Z","timestamp":1775025648924,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,5]],"date-time":"2027-02-05T00:00:00Z","timestamp":1801785600000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AR053237"],"award-info":[{"award-number":["AR053237"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AG069489"],"award-info":[{"award-number":["AG069489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX003783"],"award-info":[{"award-number":["BX003783"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX001478"],"award-info":[{"award-number":["BX001478"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["LP-922056"],"award-info":[{"award-number":["LP-922056"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bone.2026.117816","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:54:19Z","timestamp":1770105259000},"page":"117816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual inhibition of sclerostin and Notum induces synergistic osteoanabolic action in mice"],"prefix":"10.1016","volume":"206","author":[{"given":"Roy B.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April M.","family":"Hoggatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Horan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor J.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Brommage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.","family":"Robling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117816_bb0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/jbmr\/zjaf118","article-title":"Advances in Parathyroid Hormone-based medicines","volume":"40","author":"Bonnet","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/os.13136","article-title":"Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis through a Grade Analysis of Evidence","volume":"13","author":"Tian","year":"2021","journal-title":"Orthop. Surg."},{"key":"10.1016\/j.bone.2026.117816_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bone.2026.117816_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf165","article-title":"A systematic review of combination treatment strategies for osteoporosis","volume":"9","author":"Nayak","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2026.117816_bb0025","article-title":"Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bone.2026.117816_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98673","article-title":"Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition","volume":"3","author":"Witcher","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2026.117816_bb0035","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/jbmr.472","article-title":"Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury","volume":"26","author":"Li","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2106\/JBJS.22.01092","article-title":"Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates","volume":"105","author":"Florio","year":"2023","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2026.117816_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2026.117816_bb0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jbmr.4798","article-title":"Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice","volume":"38","author":"Choi","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14259","article-title":"Notum deacylates Wnt proteins to suppress signalling activity","volume":"519","author":"Kakugawa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bone.2026.117816_bb0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.devcel.2015.02.014","article-title":"Notum is required for neural and head induction via Wnt deacylation, oxidation, and inactivation","volume":"32","author":"Zhang","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2026.117816_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41586-022-04952-2","article-title":"Mechanisms and inhibition of Porcupine-mediated Wnt acylation","volume":"607","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bone.2026.117816_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-018-0038-3","article-title":"Notum inhibition increases endocortical bone formation and bone strength","volume":"7","author":"Brommage","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.bone.2026.117816_bb0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.bmcl.2016.02.021","article-title":"Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase","volume":"26","author":"Tarver","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bone.2026.117816_bb0080","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1096\/fj.201900707R","article-title":"Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans","volume":"33","author":"Moverare-Skrtic","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2026.117816_bb0085","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/jbmr.4411","article-title":"Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition","volume":"36","author":"Choi","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10462","article-title":"Improving bone health by optimizing the anabolic action of Wnt inhibitor multitargeting","volume":"5","author":"Choi","year":"2021","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2026.117816_bb0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117816_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100782","article-title":"Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer","volume":"296","author":"Zhong","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.117816_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2017.11.003","article-title":"Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists","volume":"107","author":"Holdsworth","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117816_bb0130","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1210\/jc.2013-3278","article-title":"Serum Dickkopf 1 Levels in Sclerostin Deficiency","volume":"99","author":"van Lierop","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.117816_bb0135","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.14336\/AD.2022.0315","article-title":"Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton","volume":"13","author":"Choi","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.bone.2026.117816_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100151RR","article-title":"WNT7B overexpression rescues bone loss caused by glucocorticoids in mice","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2026.117816_bb0145","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1359\/jbmr.070810","article-title":"Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation","volume":"22","author":"Bennett","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117816_bb0150","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.3654","article-title":"Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures","volume":"20","author":"Moverare-Skrtic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2026.117816_bb0155","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1056\/NEJMoa1509342","article-title":"Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle\u2019s Disease","volume":"374","author":"Kiper","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2026.117816_bb0160","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1210\/endo.140.12.7195","article-title":"Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats","volume":"140","author":"Liang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2026.117816_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MED.0000000000000507","article-title":"Combination therapies in the treatment of osteoporosis","volume":"26","author":"Kelly","year":"2019","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.bone.2026.117816_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10120902","article-title":"Dysregulated Wnt Signalling in the Alzheimer\u2019s Brain","volume":"10","author":"Aghaizu","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.bone.2026.117816_bb0175","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1136\/gutjnl-2022-329140","article-title":"APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer","volume":"72","author":"Tian","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bone.2026.117816_bb0180","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050053","article-title":"Crosstalk between androgen receptor and WNT\/beta-catenin signaling causes sex-specific adrenocortical hyperplasia in mice","volume":"16","author":"Lyraki","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bone.2026.117816_bb0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jcb.22010","article-title":"Effects of age and gender on WNT gene expression in human bone marrow stromal cells","volume":"106","author":"Shen","year":"2009","journal-title":"J. Cell. Biochem."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:44:26Z","timestamp":1775018666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"alternative-id":["S8756328226000426"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117816","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of sclerostin and Notum induces synergistic osteoanabolic action in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117816"}}